Tag: Portable Oxygen Concentrator

ORLANDO, Fla. – OxyGo is celebrating helping more than 1 million lives with its lightweight portable oxygen equipment. The company plans to host a series of events throughout the year to share the milestone with its employees and suppliers. First off: A recent socially distanced luncheon for employees, suppliers and members of the community at OxyGo locations across the country. “Being a family business and celebrating this milestone is incredible,” said V.E. Marquard-Schultz, CEO....

LONDON – Belluscura has signed its first U.S. distribution agreement for its X-PLO2R portable oxygen concentrator portfolio. The company has issued its first purchase order, with delivery expected in the third quarter, according to reports. The X-PLO2R is a lightweight POC cleared by the U.S. Food and Drug Administration designed to replace larger, metal oxygen tanks and heavier devices. Belluscura began trading on the Alternative Investment Market (AIM) on the London Stock Exchange earlier...

LONDON and PLANO, Texas – Belluscura, a medical device developer focused on lightweight and portable oxygen enrichment technology, has begun trading on the Alternative Investment Market (AIM) on the London Stock Exchange under the ticker symbol BELL.  The company has raised 17.5 million pounds supported by new and existing inventors, and it has a market cap of about 50.96 million pounds.  SPARK Advisory Partners Limited acted as the Belluscura’s sole nominated adviser...

WESTLAKE, Ohio – OxyGo, a manufacturer of lightweight portable oxygen concentrators, has acquired LIFE Corporation, a manufacturer of portable emergency oxygen and CPR administration equipment.  The acquisition will allow OxyGo to further expand its expertise in the oxygen market, says V.E. Marquard-Schultz, Esq., CEO.  “Acquiring LIFE Corp. is an exciting and logical next step in offering proactive gas solutions to the medical and industrial markets,...

LONDON — Tekcapital has announced that its portfolio company Belluscura has been granted 510(k) clearance and marketing authorization by the U.S. Food and Drug Administration for its X-PLO2R portable oxygen concentrator. "We are excited to see that the FDA has cleared the X-PLO2R device for sale, as Tekcapital and Belluscura believe it could be helpful to patients during the COVID-19 pandemic, and for many of the 250 million people worldwide suffering from COPD," said Clifford Gross, PhD, executive...

WINTER HAVEN, Fla. – 3B Medical will give away one Aer X portable oxygen concentrator every month for the next six months to a deserving patient that is struggling, has a valid oxygen prescription and would be ambulatory if they had a POC. The company is looking to partner with DME providers to identify patients in most need. “For patients without insurance or with coverage that will not cover a POC, getting a free Aer X may be life changing,” the company says. “Getting to...

BALTIMORE – The founders of OxyGEN will use their recent prize money to turn their prototype portable oxygen concentrator into an actual product.  Jessica Dakkak, Jonathan Smith and Wilson Tang were recently named the winners of an Innovation Challenge hosted by Three Lakes Foundation and MATTER for their POC combining high-flow ambient air with pulses of concentrated oxygen to provide more efficient...

YARMOUTH, Maine – As COVID-19 cases spike across the country, HME providers are seeing a spike in demand for home oxygen therapy, so much so that they’re worrying about their supply of concentrators.  Provider Woody O’Neal has seen a threefold increase in oxygen and services since December and says he’s concerned the health care system hasn’t seen the worst of it.  “My concern is that this post-holiday...

SAN DIEGO – ResMed has ended its three-year foray into the portable oxygen concentrator market due to “market conditions.”  The company says payers and HME providers are relying less on POCs for Stage 2 and Stage 3 COPD patients, dampening demand for the devices.  “ResMed has determined that it can successfully execute its respiratory care strategy and provide the most benefits to patients, HMEs, clinicians and all other stakeholders by reinvesting its...

CHELMSFORD, Mass. - ZOLL Medical has exclusive rights to distribute CAIRE's SAROS 4000 portable oxygen concentrator in all markets outside of the U.S. in combination with its EMV+ ventilator. By combining SAROS with the EMV+, remote medics will be able to deliver oxygen-enriched critical care ventilation and oxygenation therapy without the use of oxygen cylinders, which present refilling and logistical challenges, and are a hazardous threat in armed conflicts, the companies say. “The logistical...